MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6505-1191-1197$20.00
Mol Pharmacol 65:1191-1197, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mennerick, S.
Right arrow Articles by Zorumski, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mennerick, S.
Right arrow Articles by Zorumski, C. F.

Selective Antagonism of 5{alpha}-Reduced Neurosteroid Effects at GABAA Receptors

Steven Mennerick, Yejun He1, Xin Jiang, Brad D. Manion, Mingde Wang2, Amanda Shute, Ann Benz, Alex S. Evers, Douglas F. Covey, and Charles F. Zorumski

Departments of Psychiatry (S.M., Y.H., M.W., A.S., A.B., C.F.Z.), Molecular Biology and Pharmacology (X.J., A.S.E., D.F.C.), Anatomy and Neurobiology (S.M., C.F.Z.), and Anesthesiology (B.D.M., A.S.E.), Washington University School of Medicine, St. Louis, Missouri

Although neurosteroids have rapid effects on GABAA receptors, study of steroid actions at GABA receptors has been hampered by a lack of pharmacological antagonists. In this study, we report the synthesis and characterization of a steroid analog, (3{alpha},5{alpha})-17-phenylandrost-16-en-3-ol (17PA), that selectively antagonized neurosteroid potentiation of GABA responses. We examined 17PA using the {alpha}1{beta}2{gamma}2 subunit combination expressed in Xenopus laevis oocytes. 17PA had little or no effect on baseline GABA responses but antagonized both the response augmentation and the direct gating of GABA receptors by 5{alpha}-reduced potentiating steroids. The effect was selective for 5{alpha}-reduced potentiating steroids; 5{beta}-reduced potentiators were only weakly affected. Likewise, 17PA did not affect barbiturate and benzodiazepine potentiation. 17PA acted primarily by shifting the concentration response for steroid potentiation to the right, suggesting the possibility of a competitive component to the antagonism. 17PA also antagonized 5{alpha}-reduced steroid potentiation and gating in hippocampal neurons and inhibited anesthetic actions in X. laevis tadpoles. Analogous to benzodiazepine site antagonists, the development of neurosteroid antagonists may help clarify the role of GABA-potentiating neurosteroids in health and disease.


Received November 5, 2003; accepted January 23, 2004

Address correspondence to: Dr. Steven Mennerick, Department of Psychiatry, Washington University School of Medicine, 660 S. Euclid Avenue, Campus Box 8134, St. Louis, MO 63110. E-mail: menneris{at}psychiatry.wustl.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
K. A. Grant, C. M. Helms, L. S. M. Rogers, and R. H. Purdy
Neuroactive Steroid Stereospecificity of Ethanol-Like Discriminative Stimulus Effects in Monkeys
J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 354 - 361.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Li, X. Jin, D. F. Covey, and J. H. Steinbach
Neuroactive Steroids and Human Recombinant {rho}1 GABA Receptors
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 236 - 247.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu
Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System
Endocr. Rev., June 1, 2007; 28(4): 387 - 439.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Akk, P. Li, B. D. Manion, A. S. Evers, and J. H. Steinbach
Ethanol Modulates the Interaction of the Endogenous Neurosteroid Allopregnanolone with the {alpha}1beta2{gamma}2L GABAA Receptor
Mol. Pharmacol., February 1, 2007; 71(2): 461 - 472.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
Y. B. Saalmann, I. G. Morgan, and M. B. Calford
Neurosteroids Involved in Regulating Inhibition in the Inferior Colliculus
J Neurophysiol, December 1, 2006; 96(6): 3064 - 3073.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Li, D. F. Covey, J. H. Steinbach, and G. Akk
Dual Potentiating and Inhibitory Actions of a Benz[e]indene Neurosteroid Analog on Recombinant {alpha}1beta2{gamma}2 GABAA Receptors
Mol. Pharmacol., June 1, 2006; 69(6): 2015 - 2026.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. E. Shannon, P. Porcu, R. H. Purdy, and K. A. Grant
Characterization of the Discriminative Stimulus Effects of the Neuroactive Steroid Pregnanolone in DBA/2J and C57BL/6J Inbred Mice
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 675 - 685.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H.-J. Shu, L. N. Eisenman, D. Jinadasa, D. F. Covey, C. F. Zorumski, and S. Mennerick
Slow Actions of Neuroactive Steroids at GABAA Receptors
J. Neurosci., July 28, 2004; 24(30): 6667 - 6675.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics